Recognizing World Health Day

Recognizing World Health Day

04.07.11 | By

Today is World Health Day. The theme of this year's activities is focused on the important health issue of bacteria that are resistant to current medicines. Today's events highlight the urgent need for new medicines to combat the growing number of bacteria that are resistant to antibiotics and the significant challenges that resistant bacteria pose to global public health.

It is also a good time to reflect on the efforts to fight diseases of the developing world being made by the world's biopharmaceutical research companies in general and PhRMA member companies in particular.

If you've not already visited it, I recommend you take a look at the Global Health Progress (GHP) website. GHP is an initiative sponsored by world-wide biopharma companies directed at improving access to health care around the world and especially in developing countries. There's a great database available to help you learn more about the many programs working to improve the health and well-being of people around the world.

In addition, PhRMA president and CEO, John J. Castellani, was recently one of the featured speakers at a major symposium examining global health challenges hosted by the U.S. State Department. John spoke about what world-wide biopharmaceutical research companies are doing to help in the fight against disease that most affect patients in the developing world and especially neglected tropical diseases. He also highlighted the fact that, according to the G-Finder Report 2010, the biopharmaceutical research sector is the third largest investor in efforts to find solutions for global health challenges behind the U.S. government and the Gates Foundation.

More On PhRMA — powered by PhRMApedia


Cost in Context